Twelve out of 14 patients had at least one actionable genomic alteration and two patients received treatment based on the ctDNA results showing positive effects, in one patient with detectable DCP decline and in one with AFP decline and stable diseases with central necrosis of the tumor in the imaging. The gene discussed is AFP; the disease is neoplasm.